Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

Rhea-AI Summary

Harrow Health, Inc. (NASDAQ: HROW) announced it will release its fourth quarter and annual financial results for the year ending December 31, 2020, on March 8, 2021, after the market close. The financial results will be available on their website, and a conference call will occur at 4:45 p.m. ET to discuss the outcomes and present a business update. Harrow Health specializes in ophthalmic healthcare and owns ImprimisRx, a leading ophthalmology outsourcing business.

Positive

• Scheduled financial results release for Q4 and annual results on March 8, 2021.
• Conference call planned to provide business updates and engage with shareholders.

Negative

• None.

NASHVILLE, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2020, on Monday, March 8, 2021, after the Nasdaq market close. The Company will also post its fourth quarter Letter to Shareholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern time to discuss the results and provide a business update.

Conference Call Details:
Date:	Monday, March 8, 2021
Time:	4:45 p.m. Eastern time
Participant Dial-in:	(888) 506-0062 (U.S.) (973) 528-0011 (International)
Replay Dial-in (Passcode 39840): (telephonic replay through April 8, 2021)	(877) 481-4010 (U.S.) (919) 882-2331 (International)
Webcast: (online replay through June 8, 2021)	harrowinc.com

About Harrow Health
Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company. The Company owns ImprimisRx, the nation’s leading ophthalmology outsourcing and pharmaceutical compounding business, which was founded in 2014. Harrow Health also holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals, all of which started as Harrow Health subsidiaries. Harrow Health also owns royalty rights in four clinical-stage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com.

Contact:
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737

 

FAQ

When will Harrow Health release its fourth quarter results?

Harrow Health will release its fourth quarter results on March 8, 2021, after the market close.

What time is Harrow Health's conference call for financial results?

The conference call for Harrow Health's financial results will be held at 4:45 p.m. ET on March 8, 2021.

How can I access Harrow Health's financial results?

Harrow Health's financial results will be posted on their website in the 'Investors' section.

What is the stock symbol for Harrow Health?

The stock symbol for Harrow Health is HROW.